In:
The Laryngoscope, Wiley, Vol. 128, No. 4 ( 2018-04), p. 785-788
Abstract:
Endoscopic orbital decompression (EOD) is the workhorse surgical intervention for severe thyroid eye disease in Graves disease. Although EOD is a safe and effective procedure, the objective of this study is to determine the impact of orbital decompression on long‐term sinonasal‐pecific quality of life. Methods Retrospective study of 27 patients who underwent EOD by a single surgeon. The primary endpoint was change in preoperative 22‐item Sinonasal Outcomes Test (SNOT‐22) score at a minimum of 1 year. The secondary endpoint was to determine whether the performance of septoplasty for surgical access in patients without nasal obstruction impacted domain 1 (i.e., rhinologic domain) and total SNOT‐22 scores. Results The mean follow‐up was 25.7 ± 11.4 months. Domain 1 scores significantly increased at the first postoperative visit ( P ≤ 0.01) and returned to baseline values between 1 and 3 months. At 1 year, significant improvements in both total score and domain 4 and 5 (psychological and sleep dysfunction, respectively) scores were seen ( P 〈 0.01 for all scores). Septoplasty was not associated with a significant change in SNOT‐22 score at 1 year ( P = 0.48). Conclusion Endoscopic orbital decompression is associated at 1 year with a significant improvement in sinonasal‐specific quality of life, which is driven by the psychological and sleep dysfunction domains. Adjunctive septoplasty has no significant impact on SNOT‐22 scores. Level of Evidence 4. Laryngoscope , 128:785–788, 2018
Type of Medium:
Online Resource
ISSN:
0023-852X
,
1531-4995
Language:
English
Publisher:
Wiley
Publication Date:
2018
detail.hit.zdb_id:
2026089-1
